Drug intelligence / Profile preview

Octenident

Development stage
Unknown
Lead developer
Schülke & Mayr
Modality
Small Molecules
Administration
Topical
01

Overview

Octenident is an antiseptic mouthwash containing octenidine dihydrochloride as its primary active ingredient. Developed by Schülke & Mayr, it is a broad-spectrum antimicrobial agent used for the decontamination of the oral cavity and the management of oral biofilms. It is effective against a wide range of pathogens, including Gram-positive and Gram-negative bacteria, fungi, and certain viruses. The drug's mechanism of action involves the disruption of microbial cell membranes through the binding of the cationic octenidine molecule to negatively charged cell wall components, leading to cell lysis. Octenident is frequently used in clinical settings for MRSA decontamination of the oral cavity and as a therapeutic rinse to reduce inflammation in patients with periodontitis or peri-implantitis. While commercially available in some regions as a cosmetic oral hygiene product, it is actively investigated for therapeutic efficacy against specific oral infestations such as *Entamoeba gingivalis*.

Brand names
Octenident
Other names
octenidine mouthwashOctenident mouthwash

Beyond the preview

Go deeper on Octenident.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Octenident.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call